US Stock MarketDetailed Quotes

AVIR Atea Pharmaceuticals

Watchlist
  • 3.420
  • -0.040-1.16%
Close Nov 29 13:00 ET
  • 3.420
  • 0.0000.00%
Post 13:02 ET
288.86MMarket Cap-1652P/E (TTM)

Atea Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-8.79%37.2M
33.15%46.92M
67.93%69.81M
25.65%164.16M
16.73%46.57M
150.51%40.79M
9.10%35.24M
-1.44%41.57M
-38.66%130.65M
-43.80%39.9M
Selling and administrative expenses
-12.38%11.04M
-7.23%12.22M
-3.04%12.23M
2.47%49.92M
-6.72%11.53M
10.79%12.6M
5.91%13.17M
0.58%12.62M
6.40%48.71M
-6.29%12.36M
-General and administrative expense
-12.38%11.04M
-7.23%12.22M
-3.04%12.23M
2.47%49.92M
-6.72%11.53M
10.79%12.6M
5.91%13.17M
0.58%12.62M
6.40%48.71M
-6.29%12.36M
Research and development costs
-7.18%26.16M
57.26%34.7M
98.85%57.58M
39.43%114.24M
27.25%35.05M
474.54%28.18M
11.10%22.06M
-2.29%28.95M
-51.00%81.94M
-52.36%27.54M
Operating profit
8.79%-37.2M
-33.15%-46.92M
-67.93%-69.81M
-25.65%-164.16M
-16.73%-46.57M
-150.51%-40.79M
-9.10%-35.24M
1.44%-41.57M
-194.42%-130.65M
-132.93%-39.9M
Net non-operating interest income expense
-20.18%6.28M
-9.12%6.64M
9.03%6.87M
162.08%29.22M
38.76%7.76M
79.46%7.86M
576.20%7.3M
6,327.55%6.3M
5,135.21%11.15M
10,862.75%5.59M
Non-operating interest income
-20.18%6.28M
-9.12%6.64M
9.03%6.87M
162.08%29.22M
38.76%7.76M
79.46%7.86M
576.20%7.3M
6,327.55%6.3M
5,135.21%11.15M
10,862.75%5.59M
Other net income (expense)
Income before tax
6.06%-30.93M
-44.20%-40.28M
-78.45%-62.94M
-12.92%-134.94M
-13.14%-38.82M
-176.67%-32.92M
10.52%-27.93M
16.18%-35.27M
-186.22%-119.5M
-128.30%-34.31M
Income tax
2.26%226K
-3.19%243K
17.26%231K
128.36%1.02M
183.74%349K
105.77%221K
109.17%251K
197K
-120.63%-3.59M
-97.00%123K
Net income
6.01%-31.15M
-43.78%-40.52M
-78.11%-63.17M
-17.30%-135.96M
-13.75%-39.16M
-310.89%-33.14M
10.06%-28.18M
15.71%-35.47M
-195.64%-115.91M
-129.40%-34.43M
Net income continuous Operations
6.01%-31.15M
-43.78%-40.52M
-78.11%-63.17M
-17.30%-135.96M
-13.75%-39.16M
-310.89%-33.14M
10.06%-28.18M
15.71%-35.47M
-195.64%-115.91M
-129.40%-34.43M
Minority interest income
Net income attributable to the parent company
6.01%-31.15M
-43.78%-40.52M
-78.11%-63.17M
-17.30%-135.96M
-13.75%-39.16M
-310.89%-33.14M
10.06%-28.18M
15.71%-35.47M
-195.64%-115.91M
-129.40%-34.43M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
6.01%-31.15M
-43.78%-40.52M
-78.11%-63.17M
-17.30%-135.96M
-13.75%-39.16M
-310.89%-33.14M
10.06%-28.18M
15.71%-35.47M
-195.64%-115.91M
-129.40%-34.43M
Basic earnings per share
7.50%-0.37
-41.18%-0.48
-74.42%-0.75
-17.27%-1.63
-14.63%-0.47
-300.00%-0.4
10.53%-0.34
15.69%-0.43
-195.21%-1.39
-129.08%-0.41
Diluted earnings per share
7.50%-0.37
-41.18%-0.48
-74.42%-0.75
-17.27%-1.63
-14.63%-0.47
-300.00%-0.4
10.53%-0.34
15.69%-0.43
-201.46%-1.39
-130.60%-0.41
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -8.79%37.2M33.15%46.92M67.93%69.81M25.65%164.16M16.73%46.57M150.51%40.79M9.10%35.24M-1.44%41.57M-38.66%130.65M-43.80%39.9M
Selling and administrative expenses -12.38%11.04M-7.23%12.22M-3.04%12.23M2.47%49.92M-6.72%11.53M10.79%12.6M5.91%13.17M0.58%12.62M6.40%48.71M-6.29%12.36M
-General and administrative expense -12.38%11.04M-7.23%12.22M-3.04%12.23M2.47%49.92M-6.72%11.53M10.79%12.6M5.91%13.17M0.58%12.62M6.40%48.71M-6.29%12.36M
Research and development costs -7.18%26.16M57.26%34.7M98.85%57.58M39.43%114.24M27.25%35.05M474.54%28.18M11.10%22.06M-2.29%28.95M-51.00%81.94M-52.36%27.54M
Operating profit 8.79%-37.2M-33.15%-46.92M-67.93%-69.81M-25.65%-164.16M-16.73%-46.57M-150.51%-40.79M-9.10%-35.24M1.44%-41.57M-194.42%-130.65M-132.93%-39.9M
Net non-operating interest income expense -20.18%6.28M-9.12%6.64M9.03%6.87M162.08%29.22M38.76%7.76M79.46%7.86M576.20%7.3M6,327.55%6.3M5,135.21%11.15M10,862.75%5.59M
Non-operating interest income -20.18%6.28M-9.12%6.64M9.03%6.87M162.08%29.22M38.76%7.76M79.46%7.86M576.20%7.3M6,327.55%6.3M5,135.21%11.15M10,862.75%5.59M
Other net income (expense)
Income before tax 6.06%-30.93M-44.20%-40.28M-78.45%-62.94M-12.92%-134.94M-13.14%-38.82M-176.67%-32.92M10.52%-27.93M16.18%-35.27M-186.22%-119.5M-128.30%-34.31M
Income tax 2.26%226K-3.19%243K17.26%231K128.36%1.02M183.74%349K105.77%221K109.17%251K197K-120.63%-3.59M-97.00%123K
Net income 6.01%-31.15M-43.78%-40.52M-78.11%-63.17M-17.30%-135.96M-13.75%-39.16M-310.89%-33.14M10.06%-28.18M15.71%-35.47M-195.64%-115.91M-129.40%-34.43M
Net income continuous Operations 6.01%-31.15M-43.78%-40.52M-78.11%-63.17M-17.30%-135.96M-13.75%-39.16M-310.89%-33.14M10.06%-28.18M15.71%-35.47M-195.64%-115.91M-129.40%-34.43M
Minority interest income
Net income attributable to the parent company 6.01%-31.15M-43.78%-40.52M-78.11%-63.17M-17.30%-135.96M-13.75%-39.16M-310.89%-33.14M10.06%-28.18M15.71%-35.47M-195.64%-115.91M-129.40%-34.43M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 6.01%-31.15M-43.78%-40.52M-78.11%-63.17M-17.30%-135.96M-13.75%-39.16M-310.89%-33.14M10.06%-28.18M15.71%-35.47M-195.64%-115.91M-129.40%-34.43M
Basic earnings per share 7.50%-0.37-41.18%-0.48-74.42%-0.75-17.27%-1.63-14.63%-0.47-300.00%-0.410.53%-0.3415.69%-0.43-195.21%-1.39-129.08%-0.41
Diluted earnings per share 7.50%-0.37-41.18%-0.48-74.42%-0.75-17.27%-1.63-14.63%-0.47-300.00%-0.410.53%-0.3415.69%-0.43-201.46%-1.39-130.60%-0.41
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data